124 related articles for article (PubMed ID: 28196745)
21. Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement.
Dahan R; Barnhart BC; Li F; Yamniuk AP; Korman AJ; Ravetch JV
Cancer Cell; 2016 Jun; 29(6):820-831. PubMed ID: 27265505
[TBL] [Abstract][Full Text] [Related]
22. Antibody C region influences TGN1412-like functional activity in vitro.
Ball C; Fox B; Hufton S; Sharp G; Poole S; Stebbings R; Eastwood D; Findlay L; Parren PW; Thorpe R; Bristow A; Thorpe SJ
J Immunol; 2012 Dec; 189(12):5831-40. PubMed ID: 23150712
[TBL] [Abstract][Full Text] [Related]
23. First Infusion Reactions are Mediated by FcγRIIIb and Neutrophils.
Weber F; Breustedt D; Schlicht S; Meyer CA; Niewoehner J; Ebeling M; Freskgard PO; Bruenker P; Singer T; Reth M; Iglesias A
Pharm Res; 2018 Jun; 35(9):169. PubMed ID: 29951887
[TBL] [Abstract][Full Text] [Related]
24. Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases.
Chan KR; Ong EZ; Mok DZ; Ooi EE
Expert Rev Anti Infect Ther; 2015; 13(11):1351-60. PubMed ID: 26466016
[TBL] [Abstract][Full Text] [Related]
25. Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development.
Barb AW
J Biol Chem; 2021; 296():100057. PubMed ID: 33172893
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
[TBL] [Abstract][Full Text] [Related]
27. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.
Zhang X; Olsen HS; Chen S; So E; Zhou H; Burch E; Mérigeon EY; Block DS; Strome SE
J Immunol; 2016 Feb; 196(3):1165-76. PubMed ID: 26695368
[TBL] [Abstract][Full Text] [Related]
29. Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.
Moussa EM; Kotarek J; Blum JS; Marszal E; Topp EM
Pharm Res; 2016 Jul; 33(7):1736-51. PubMed ID: 27037576
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB.
Manso T; Kushwaha A; Abdollahi N; Duroux P; Giudicelli V; Kossida S
Front Immunol; 2023; 14():1129323. PubMed ID: 37215135
[TBL] [Abstract][Full Text] [Related]
31. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
Pollastrini J; Dillon TM; Bondarenko P; Chou RY
Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
[TBL] [Abstract][Full Text] [Related]
32. Is an in vitro whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?
Iwata Y; Harada A; Hara T; Kubo C; Inoue T; Tabo M; Ploix C; Manigold T; Hinton H; Mishima M
J Toxicol Sci; 2016; 41(4):523-31. PubMed ID: 27432238
[TBL] [Abstract][Full Text] [Related]
33. Enhanced T-cell responses to glioma cells coated with the anti-EGF receptor antibody and targeted to activating FcgammaRs on human dendritic cells.
Banerjee D; Matthews P; Matayeva E; Kaufman JL; Steinman RM; Dhodapkar KM
J Immunother; 2008; 31(2):113-20. PubMed ID: 18481381
[TBL] [Abstract][Full Text] [Related]
34. Differential and sequential immunomodulatory role of neutrophils and Ly6C
Lambour J; Naranjo-Gomez M; Boyer-Clavel M; Pelegrin M
Emerg Microbes Infect; 2021 Dec; 10(1):964-981. PubMed ID: 33858301
[TBL] [Abstract][Full Text] [Related]
35. Fcγ Receptor Function and the Design of Vaccination Strategies.
Bournazos S; Ravetch JV
Immunity; 2017 Aug; 47(2):224-233. PubMed ID: 28813656
[TBL] [Abstract][Full Text] [Related]
36. Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors.
Loyau J; Malinge P; Daubeuf B; Shang L; Elson G; Kosco-Vilbois M; Fischer N; Rousseau F
MAbs; 2014; 6(6):1621-30. PubMed ID: 25484053
[TBL] [Abstract][Full Text] [Related]
37. Role of Fcgamma receptors in glomerulonephritis.
Tarzi RM; Cook HT
Nephron Exp Nephrol; 2003; 95(1):e7-12. PubMed ID: 14520009
[TBL] [Abstract][Full Text] [Related]
38. Requirement of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor-Induced Arthritis, but Not Fcγ Receptor-Mediated Platelet Elimination, in Mice.
Martin K; Touil R; Cvijetic G; Israel L; Kolb Y; Sarret S; Valeaux S; Degl'Innocenti E; Le Meur T; Caesar N; Bardet M; Beerli C; Zerwes HG; Kovarik J; Beltz K; Schlapbach A; Quancard J; Régnier CH; Bigaud M; Junt T; Wieczorek G; Isnardi I; Littlewood-Evans A; Bornancin F; Calzascia T
Arthritis Rheumatol; 2020 Jun; 72(6):919-930. PubMed ID: 31943941
[TBL] [Abstract][Full Text] [Related]
39. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
[TBL] [Abstract][Full Text] [Related]
40. The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies.
Hogarth PM; Anania JC; Wines BD
Curr Top Microbiol Immunol; 2014; 382():321-52. PubMed ID: 25116107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
